Northern Trust Corp Merus N.V. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Merus N.V. stock. As of the latest transaction made, Northern Trust Corp holds 48,940 shares of MRUS stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,940

Previous 51,581 5.12%

Holding current value

$2.31 Million

Previous $2.32 Million 24.68%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$39.81 - $60.2 $105,138 - $158,988	-2,641 Reduced 5.12%	48,940 $2.9 Million
Q1 2024 May 14, 2024	SELL	$28.03 - $51.82 $85,827 - $158,672	-3,062 Reduced 5.6%	51,581 $2.32 Million
Q4 2023 Feb 13, 2024	SELL	$20.06 - $28.66 $133,639 - $190,932	-6,662 Reduced 10.87%	54,643 $1.5 Million
Q3 2023 Nov 13, 2023	BUY	$20.13 - $27.29 $207,218 - $280,923	10,294 Added 20.18%	61,305 $1.45 Million
Q2 2023 Aug 11, 2023	SELL	$18.33 - $27.18 $12,299 - $18,237	-671 Reduced 1.3%	51,011 $1.34 Million
Q1 2023 May 15, 2023	SELL	$14.25 - $20.5 $11,955 - $17,199	-839 Reduced 1.6%	51,682 $950,000
Q4 2022 Feb 13, 2023	BUY	$12.8 - $23.66 $27,865 - $51,507	2,177 Added 4.32%	52,521 $812,000
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $32,526 - $50,482	1,745 Added 3.59%	50,344 $1.01 Million
Q2 2022 Aug 12, 2022	BUY	$13.98 - $29.25 $5,004 - $10,471	358 Added 0.74%	48,599 $1.1 Million
Q1 2022 May 13, 2022	SELL	$23.58 - $30.91 $125,162 - $164,070	-5,308 Reduced 9.91%	48,241 $1.28 Million
Q4 2021 Feb 08, 2022	BUY	$20.0 - $32.29 $159,100 - $256,866	7,955 Added 17.45%	53,549 $1.7 Million
Q3 2021 Nov 15, 2021	SELL	$16.48 - $27.23 $116,694 - $192,815	-7,081 Reduced 13.44%	45,594 $1 Million
Q2 2021 Aug 13, 2021	SELL	$20.0 - $25.48 $84,380 - $107,500	-4,219 Reduced 7.42%	52,675 $1.11 Million
Q1 2021 May 12, 2021	SELL	$16.14 - $29.11 $219,148 - $395,255	-13,578 Reduced 19.27%	56,894 $1.19 Million
Q4 2020 Feb 11, 2021	SELL	$11.4 - $18.36 $98,062 - $157,932	-8,602 Reduced 10.88%	70,472 $1.24 Million
Q3 2020 Nov 16, 2020	BUY	$10.57 - $16.0 $18,687 - $28,288	1,768 Added 2.29%	79,074 $949,000
Q2 2020 Aug 14, 2020	BUY	$10.5 - $17.36 $690,627 - $1.14 Million	65,774 Added 570.36%	77,306 $1.24 Million
Q1 2020 May 14, 2020	SELL	$11.34 - $19.44 $5,692 - $9,758	-502 Reduced 4.17%	11,532 $140,000
Q4 2019 Feb 14, 2020	BUY	$14.08 - $18.5 $31,370 - $41,218	2,228 Added 22.72%	12,034 $169,000
Q3 2019 Nov 13, 2019	BUY	$14.55 - $20.52 $142,677 - $201,219	9,806 New	9,806 $175,000

Others Institutions Holding MRUS

# of Institutions

188

Shares Held

59M

Call Options Held

345K

Put Options Held

222K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.16B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Merus N.V. Transaction History